Gradient Investments LLC Takeda Pharmaceutical CO LTD Transaction History

Gradient Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$13.36 - $15.43 $6,680 - $7,715	-500 Reduced 51.12%	478 $6,000
Q3 2023 Oct 27, 2023	BUY	$15.03 - $16.32 $7,515 - $8,160	500 Added 104.6%	978 $15,000
Q3 2020 Oct 06, 2020	SELL	$17.1 - $19.19 $3,898 - $4,375	-228 Reduced 32.29%	478 $9,000
Q2 2020 Jul 10, 2020	BUY	$14.59 - $19.5 $3,326 - $4,446	228 Added 47.7%	706 $13,000
Q1 2019 Apr 11, 2019	BUY	$16.7 - $21.52 $3,206 - $4,131	192 Added 67.13%	478 $10,000
Q4 2018 Jan 18, 2019	BUY	$15.64 - $21.1 $4,473 - $6,034	286 New	286 $5,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.